Publications
Sort:
Issue
Effect of TNTs-mediated mitochondrial transfer between mesenchymal stem cells and endothelial cells on vascularization in vitro
Journal of Army Medical University 2022, 44(4): 310-319
Published: 28 February 2022
Abstract PDF (2.6 MB) Collect
Downloads:0
Objective

To explore the effect of tunneling nanotubes (TNTs) within mesenchymal stem cells (MSC)/human umbilical vein endothelial cells (HUVEC) co-culture cell spheroids on endothelial cell angiogenesis.

Methods

Pre-vascular network formation assay was used to compare the angiogenic ability among the MSC/HUVEC cell spheroid co-culture group, adherent co-culture group, HUVEC 3D culture group and MSC 3D culture group. The expression of β-catenin protein was detected by Western blotting and immunofluorescence staining. The cell spheroids were treated with microfilament depolymerization reagent (CytoD) as a control group, and the above parameters were tested again in the untreated and treated groups. The structure of TNTs was verified by fluorescent labeling and field emission scanning electron microscopy, mitochondrial communication was observed by adenovirus infection, and the mitochondrial status was assessed by mitochondrial membrane potential assay.

Results

Compared with the MSC/HUVEC cell spheroid co-culture group, the numbers of junctions and meshes were significantly lower in the adherent co-culture group, HUVEC 3D culture group and MSC 3D culture group (P<0.05). Immunofluorescence staining for β-catenin protein suggested that the spheroid co-culture group had stronger expression than the adherent co-culture group. The results of Western blotting also showed that the intracellular β-catenin expression in the spheroid co-culture group was significantly higher than that in the adherent co-culture group (P<0.05). The presence of TNT (F-actin) between MSC and HUVEC in the co-culture cellular spheroids was shown by phalloidine staining. When the cells were co-cultured as spheroids, the mitochondria derived from HUVEC were observed intracellularly in MSC, and the mitochondria derived from MSC were also observed intracellularly in HUVEC, and the above mitochondrial exchange was diminished in the CytoD-treated group. The mitochondrial membrane potential of the CytoD-treated spheroids was significantly lower than that of the untreated spheroids (P<0.05), and the proliferation rate and migration range of HUVEC were lower and smaller than those of the untreated spheroids. Compared with the untreated cell spheroid group, the numbers of junctions and meshes were significantly lower in the CytoD-treated cell spheroid group (P<0.05). The total amount of β-catenin protein was significantly higher in the untreated cell spheroid group compared to the CytoD-treated group (P<0.05).

Conclusion

Within the co-culture cell spheroids, there are TNTs and their mediated bidirectional mitochondrial transfer between MSC and HUVEC, and they affect the angiogenic ability of HUVEC within these cellular spheroids probably through β-catenin related pathways.

Open Access Full Length Article Issue
Identification of ferroptosis-associated tumor antigens as the potential targets to prevent head and neck squamous cell carcinoma
Genes & Diseases 2024, 11(6): 101212
Published: 19 January 2024
Abstract PDF (5 MB) Collect
Downloads:2

Head and neck squamous cell carcinoma (HNSC) represents nearly 90% of all head and neck tumors. The current treatment modality for HNSC patients primarily involves surgical intervention and radiotherapy, but its therapeutic efficacy remains limited. The mRNA vaccine based on tumor antigens seems promising for cancer treatment. Ferroptosis, a novel form of cell death, is linked to tumor progression and cancer immunotherapy. Nevertheless, the effectiveness of ferroptosis-associated tumor antigens in treating HNSC remains uncertain. In this study, we identified three ferroptosis-associated tumor antigens, namely caveolin1 (CAV1), ferritin heavy chain (FTH1), and solute carrier 3A2 (SLC3A2), as being overexpressed and mutated based on data obtained from The Cancer Genome Atlas and Gene Expression Omnibus databases. These antigens were strongly associated with poor prognosis and infiltration of antigen-presenting cells in HNSC. We further identified two ferroptosis subtypes (FS1 and FS2) with distinct molecular, cellular, and clinical properties to identify antigen-sensitive individuals. Our findings indicate that FS1 exhibits an immune “hot” phenotype, whereas FS2 displays an immune “cold” phenotype. Additionally, differential expression of immunogenic cell death modulators and immune checkpoints was observed between these two immune subtypes. Further exploration of the HNSC’s immune landscape revealed significant heterogeneity among individual patients. Our findings suggest that CAV1, FTH1, and SLC3A2 are potential targets to prevent HNSC in FS2 patients. Overall, our research reveals the potential of ferroptosis-associated mRNA vaccines for HNSC and identifies an effective patient population for vaccine treatment.

Total 2
1/11GOpage